Usnic acid, a natural antimicrobial agent able to inhibit bacterial biofilm formation on polymer surfaces

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 11, 2004, Pages 4360-4365

  Francolini, I ^a,b   Norris, P ^a   Piozzi, A ^b   Donelli, G ^c   Stoodley, P ^a,d  

^a MONTANA STATE UNIVERSITY   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d ALLEGHENY SINGER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; POLYMER; POLYURETHAN; USNIC ACID;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ADHERENCE; BIOFILM; CELL KILLING; CONTROLLED STUDY; DRUG MECHANISM; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FUNGUS; GRAM POSITIVE BACTERIUM; IMAGE ANALYSIS; INFECTION RESISTANCE; LAMINAR FLOW; MORPHOLOGY; NONHUMAN; PLANKTON; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; SURFACE PROPERTY;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL ADHESION; BENZOFURANS; BIOFILMS; GREEN FLUORESCENT PROTEINS; MICROSCOPY, CONFOCAL; POLYMERS; POLYURETHANES; STAPHYLOCOCCUS AUREUS; SURFACE PROPERTIES;

EID: 7244247146     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.11.4360-4365.2004     Document Type: Article

References (40)

1. Bach, A., H. Eberhardt, A. Frick, H. Schmidt, B. W. Bottinger, and E. Martin. 1999. Efficacy of silver-coating central venous catheters in reducing bacterial colonization. Crit. Care Med. 27:515-520.
2. Campanella, L., M. Delfini, P. Ercole, A. Iacoangeli, and G. Risuleo. 2002. Molecular characterization and action of usnic acid: a drug that inhibits proliferation of mouse polyomavirus in vitro and whose main target is RNA transcription. Biochimie 84:329-334.
3. Costerton, J. W., P. S. Stewart, and E. P. Greenberg. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322.
4. Craig, W. A. 1988. Do antibiotic combinations prevent the emergence of resistant organisms? Infect. Control Hosp. Epidemiol. 9:417-419.
5. Davies, D. G., M. R. Parsek, J. P. Pearson, B. H. Iglewski, J. W. Costerton, and E. P. Greenberg. 1998. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280:295-298.
6. Donelli, G., I. Francolini, A. Piozzi, R. Di Rosa, and W. Marconi. 2002. New polymer-antibiotic systems to inhibit bacterial biofilm formation: a suitable approach to prevent central venous catheter-associated infections. J. Chemother. 14:501-507.
7. Donelli, G., and I. Francolini. 2001. Efficacy of antiadhesive, antibiotic and antiseptic coatings in preventing catheter-related infections: review. J. Chemother. 13:595-606.
8. Evans, D. J., D. G. Allison, M. R. W. Brown, and F. Gilbert. 1990. Effect of growth-rate on resistance of gram-negative biofilms to cetrimide. J. Antimicrob. Chemother. 26:473-478.
9. Flowers, R. H., K. J. Schwenzer, R. F. Kopel, M. J. Fish, S. I. Tucker, and B. M. Farr. 1989. Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection. A randomized controlled trial. JAMA 261:878-883.
10. Ghione, M., D. Parrello, and L. Grasso. 1988. Usnic acid revisited, its activity on oral flora. Chemioterapia 7:302-305.
11. Grasso, L., P. E. Ghirardi, and M. Ghione. 1989. Usnic acid, a selective antimicrobial agent against Streptococcus mutans: a pilot clinical study. Curr. Ther. Res. 45:1067-1070.
12. Hentzer, M., H. Wu, J. B. Andersen, K. Riedel, T. B. Rasmussen, N. Bagge, N. Kumar, M. A. Schembri, Z. Song, P. Kristoffersen, M. Manefield, J. W. Costerton, S. Molin, L. Eber, P. Steinberg, S. Kjelleberg, N. Høiby, and M. Givskov. 2003. Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. EMBO J. 22:3803-3815.
13. Hentzer, M., K. Riedel, T. B. Rasmussen, A. Heydorn, J. B. Andersen, M. R. Parsek, S. A. Rice, L. Eberl, S. Molin, N. Hoiby, S. Kjelleberg, and M, Givskov. 2002. Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound. Microbiology 148: 87-102.
14. Heydorn, A., A. T. Nielsen, M. Hentzer, C. Stenberg, M. Giskov, B. K. Ersboll, and S. Molin. 2000. Quantification of biofilm structure by the novel computer program COMSTAT. Microbiology 146:2395-2407.
15. Hjelmgaard, T., T. Persson, T. B. Rasmussen, M. Givskov, and J. Nielsen. 2003. Synthesis of furanone-based natural product analogues with quorum sensing antagonist activity. Bioorg. Med. Chem. 11:3261-3271.
16. Kahl, B. C., M. Goulian, W. Van Wamel, M. Herrmann, S. M. Simon, G. Kaplan, G. Peters, and A. L. Cheung. 2000. Staphylococcus aureus RN6390 replicates and induces apoptosis in a pulmonary epithelial cell line. Infect. Immun. 68:5385-5392.
17. Klausen, M., A. Aaes-Jorgensen, S. Molin, and T. Tolker-Nielsen. 2003. Involvement of bacterial migration in the development of complex multicellular structures in Pseudomonas aeruginosa biofilms. Mol. Microbiol. 50:61-68.
18. Krishna, D. R., and D. Venkataramana. 1992. Pharmacokinetics of D(+)-usnic acid after intravenous and oral administration. Drug Metab. Dispos. 20:909-911.
19. Lautwerwein, M., M. Oethinger, K. Belsner, T. Peters, and R. Marre. 1995. In vitro activities of the lichen secondary metabolites vulpinic acid, (+)-usnic acid, and (-)-usnic acid against aerobic and anaerobic microorganisms. Antimicrob. Agents Chemother. 39:2541-2543.
20. Leid, J. G., M. E. Shirtliff, J. W. Costerton, and P. Stoodley. 2002. Human leukocytes adhere, penetrate, and respond to Staphylococcus aureus biofilms. Infect. Immun. 70:6339-6345.
21. Lodetti, G., P. Gigola, B. Bertasi, F. D'Ambrosca, G. Ponchio, M. Fishbach, and M. N. Losio. 2000. Valutazione in vitro della citotossicità indotta da prodotti per l'igiene orale contenenti l'acido usnico, agente antimicrobico naturale estratto dai licheni. Gimmoc 4:67-72.
22. Mah, T. F., and G. A. O'Toole. 2001. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 9:34-39.
23. Maki, D. G., S. M. Stolz, S. J. Wheeler, and L. A. Mermel. 1997. Prevention of central-venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. Ann. Intern. Med. 127:257-266.
24. Marconi, W., A. Galloppa, A. Martinelli, and A. Piozzi. 1996. New polyurethane compositions able to bond high amounts of both albumin and heparin. II: Copolymers and polymer blends. Biomaterials 17:1795-1802.
25. Marconi, W., I. Francolini, A. Piozzi, and R. Di Rosa. 2001. Antibiotic releasing urethane polymers for prevention of catheter related infections. J. Bioact. Compat. Polym. 16:393-407.
26. National Committee for Clinical Laboratory Standards. 1990. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. M7-A2. National Committee for Clinical Laboratory Standards, Villanova, Pa.
27. O'Grady, N. P., M. Alexander, E. P. Dellinger, J. L. Gerberding, S. O. Heard, D. G. Maki, H. Masur, R. D. McCormick, L. A. Mermel, M. L. Pearson, I. I. Raad, A. Randolph, and R. A. Weinstein. 2002. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. Morb. Mortal. Wkly. Rep. 9:1-29.
28. Purevdorj, B., J. W. Costerton, and P. Stoodley. 2002. Influence of hydrodynamics and cell signaling on the structure and behavior of Pseudomonas aeruginosa biofilms. Appi. Environ. Microbiol. 68:4457-4464.
29. Raad, I., R. Darouiche, R. Hachem, M. Mansouri, and G. P. Bodey. 1996. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. J. Infect. Dis. 173:418-424.
30. Schierholz, J. M., L. J. Lucas, A. Rump, and G. Pulverer. 1998. Efficacy of silver-coated medical devices. J. Hosp. Infect. 40:257-262.
31. Sharma, R. K., and P. J. Jannke. 1966. Acidity of usnic acid. Ind. J. Chem. 4:16-18.
32. Sherertz, R. J., W. A. Carruth, A. A. Hampton, M. P. Byron, and D. D. Solomon. 1993. Efficacy of antibiotic-coated catheters in preventing subcutaneous Staphylococcus aureus infection in rabbits. J. Infect. Dis. 167:98-106.
33. Shibata, S., T. Ukita, T. Tamura, and Y. Miura. 1948. Relation between chemical constitutions and antibacterial effects of usnic acid and derivates. Jpn. Med. J. 1:152-155.
34. Stewart, P. S., and J. W. Costerton. 2001. Antibiotic resistance of bacteria in biofilms. Lancet 358:135-138.
35. Stoodley, P., and B. K. Warwood. 2003. Use of flow cells and annular reactors to study biofilms, p. 197-213. In P. Lens, A. P. Moran, T. Mahony, P. Stoodley, and V. O'Flaherty (ed.), Biofilms in medicine, industry and environmental biotechnology, 1st ed. IWA Publishing, London, United Kingdom.
36. Stoodley, P., K. Sauer, D. G. Davies, and J. W. Costerton. 2002. Biofilm as complex differentiated communities. Annu. Rev. Microbiol. 56:187-209.
37. Suci, P. A., M. W. Mittelman, F. P. Yu, and G. G. Geesey. 1994. Investigation of ciprofloxacin penetration into Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 38:2125-2133.
38. Takani, M., T. Yajima, H. Masuda, and O. Yamauchi. 2002. Spectroscopic and structural characterization of copper(II) and palladium(II) complexes of a lichen substance usnic acid and its derivatives. Possible forms of environmental metals retained in lichens. J. Inorg. Biochem. 91:139-150.
39. Tebbs, S. E., and T. S. J. Elliott. 1993. A novel antimicrobial central venous catheter impregnated with benzalkonium chloride. J. Antimicrob. Chemother. 31:261-271.
40. Vijayakumar, C. S., S. Viswanathan, M. Kannappa Reddy, S. Parvathavarthini, A. B. Kundu, and E. Sukumar. 2000. Anti-inflammatory activity of (+)-usnic acid. Fitoterapia 71:564-566.